Company Precipio, Inc.

Equities

PRPO

US74019L6020

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Quarterly earnings - Rate of surprise

Sector Medical Diagnostic & Testing Equipment

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-19 pm EDT			5-day change	1st Jan Change
6.2 ^USD	-7.53%		-6.82%	-4.62%

Apr. 01	Transcript : Precipio, Inc. - Special Call
Mar. 29	Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Companyâs technologies include HemeScreen and IV-Cell. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its technology enables testing to be completed in one rapid scanning process. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. The Companyâs laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.

Number of employees: 54

USD in Million	2022	Weight	2023	Weight	Delta
Diagnostic Service 80.1 %	8	89.4 %	12	80.1 %	+44.67%
Other 19.9 %	1	14.9 %	3	19.9 %	+115.34%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	9	100.0 %	15	100.0 %	+61.46%

Managers	Title	Age	Since
Ilan Danieli CEO	Chief Executive Officer	52	17-06-27
Matthew Gage DFI	Director of Finance/CFO	57	17-06-30
Ayman Mohamed CTO	Chief Tech/Sci/R&D Officer	39	-
Ahmed Zaki Sabet COO	Chief Operating Officer	68	18-08-06
Miri Chiko-Radomski HRO	Human Resources Officer	-	-

Members of the board	Title	Age	Since
Ronald Andrews BRD	Director/Board Member	64	21-02-28
Kathy LaPorte BRD	Director/Board Member	62	18-08-08
Richard Sandberg CHM	Chairman	80	19-12-02
Christina Valauri BRD	Director/Board Member	-	Dec. 31
Ilan Danieli CEO	Chief Executive Officer	52	17-06-27
Jeffrey Cossman BRD	Director/Board Member	77	17-09-25
David Cohen BRD	Director/Board Member	65	17-11-07

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,430,292	1,372,046 ( 95.93 %)	0	95.92 %
Stock B	0	47	0	0

Name	Equities	%	Valuation
David Cohen 3.010 %	42,746	3.010 %	286 398 $
Kennedy Capital Management LLC 2.782 %	39,503	2.782 %	264 670 $
Vanguard Group, Inc. (Subfiler) 2.708 %	38,458	2.708 %	257 669 $
BlackRock Institutional Trust Co. NA 2.040 %	28,972	2.040 %	194 112 $
Richard Sandberg 1.129 %	16,033	1.129 %	107 421 $
Geode Capital Management LLC 1.010 %	14,350	1.010 %	96 145 $
Walleye Capital LLC 0.9390 %	13,335	0.9390 %	89 345 $
G1 Execution Services LLC 0.8104 %	11,509	0.8104 %	77 110 $
Kathy LaPorte 0.7092 %	10,071	0.7092 %	67 476 $
Jeffrey Cossman 0.5958 %	8,461	0.5958 %	56 689 $

Precipio, Inc.

4 Science Park 3rd Floor

06511, New Haven

+203 787 7888

http://www.precipiodx.com

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
PRECIPIO, INC.	-4.62%	9.59M
QUIDELORTHO CORPORATION	-46.92%	2.56B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+7.27%	1.66B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-15.17%	1.45B
BIOTAGE AB	+18.55%	1.2B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-15.69%	978M
CONTEC MEDICAL SYSTEMS CO.,LTD	-24.43%	875M
REVENIO GROUP OYJ	-9.20%	698M
VAREX IMAGING CORPORATION	-17.12%	687M
CELLAVISION AB	+5.90%	480M

Medical Diagnostic & Testing Equipment